INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 92 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,184,000 | -0.9% | 144,713 | +0.1% | 0.00% | 0.0% |
| Q3 2016 | $2,203,000 | -71.4% | 144,534 | -27.2% | 0.00% | -70.0% |
| Q2 2016 | $7,712,000 | +65.5% | 198,655 | +18.5% | 0.01% | +66.7% |
| Q1 2016 | $4,659,000 | -44.5% | 167,595 | +7.3% | 0.01% | -45.5% |
| Q4 2015 | $8,399,000 | +44.0% | 156,141 | +7.2% | 0.01% | +37.5% |
| Q3 2015 | $5,831,000 | +51.3% | 145,639 | +20.8% | 0.01% | +60.0% |
| Q2 2015 | $3,853,000 | +27.7% | 120,602 | -4.5% | 0.01% | +25.0% |
| Q1 2015 | $3,017,000 | +56.2% | 126,321 | +15.5% | 0.00% | +33.3% |
| Q4 2014 | $1,931,000 | +28.1% | 109,390 | -0.5% | 0.00% | +50.0% |
| Q3 2014 | $1,507,000 | -17.9% | 109,955 | +1.0% | 0.00% | 0.0% |
| Q2 2014 | $1,836,000 | – | 108,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
| Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
| Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
| Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
| Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
| GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
| Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
| WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |